📢 Publish Your Research for Free - Full APC Waiver, No Hidden Charges. Submit Your Article Today! Submit Now →
JImage

ARTICLE TYPE : RESEARCH ARTICLE

Published on :   03 Dec 2025, Volume - 1
Journal Title :   WebLog Journal of Orthopaedics | WebLog J Orthop
Source URL:   weblog iconhttps://weblogoa.com/articles/wjor.2025.l0303
Permanent Identifier (DOI) :  doi iconhttps://doi.org/10.5281/zenodo.17865918

Intraoperative Ketamine and Postoperative Outcomes After Total Knee Arthroplasty: Association with Revision Surgery and Analgesic Use

Tegshjargal Baasansukh 1
Sarah Gore 1
Chukwudalu Ononenyi 1
Rawan Elkomi 2
Malachi Scott 1
Syed Fahad Gillani 2
Mekdem Bisrat 2 *
Miriam Michael 2,3
1College of Medicine, Howard University, Washington, DC, USA
2Department of Internal Medicine, Howard University College of Medicine, Washington, USA
3Department of Internal Medicine, University of Maryland School of Medicine, Baltimore, USA

Abstract

Background: Ketamine is widely used as an anesthetic adjunct in total knee arthroplasty (TKA), yet its association with surgical revision and postoperative analgesic exposure remains unclear.

Objectives: To evaluate the association between intraoperative ketamine and one-year revision surgery as well as early postoperative analgesic exposure following primary TKA.

Methods: We conducted a retrospective, propensity-matched cohort study on the TriNetX Global Collaborative Network. Adults undergoing primary TKA with documented intraoperative ketamine were compared to those without ketamine exposure. Matching used demographic, diagnostic, and perioperative factors. Outcomes included one-year arthroplastic revision, 90-day exposure to any analgesic and specific classes (opioids, NSAIDs, acetaminophen), and prescription counts.

Results: After 1:1 matching, 31,575 ketamine-exposed patients were compared with 31,575 controls. Ketamine exposure was associated with higher one-year revision risk (1.7% vs 1.2%; HR 1.38, p<0.001) and increased 90-day exposure to any analgesic (87.3% vs 84.1%; RR 1.04; HR 1.09, p<0.001) and opioids (83.1% vs 79.8%; RR 1.04; HR 1.09, p<0.001), while NSAID exposure was slightly lower (5.3% vs 5.9%; RR 0.90; HR 0.91, p<0.001). The mean number of prescriptions among exposed patients was modestly lower in the ketamine group.

Conclusion: In this large multicenter cohort, intraoperative ketamine was associated with greater risks of revision surgery and early postoperative opioid and analgesic exposure. While confounding by indication is possible, these findings raise concerns about ketamine’s long-term impact in TKA. Prospective randomized studies are warranted.

Keywords: Total Knee Arthroplasty; Ketamine; Revision Surgery; Postoperative Analgesia; Opioid Exposure

Citation

Baasansukh T, Gore S, Ononenyi C, Elkomi R, Scott M, Gillani SF, et al. Intraoperative Ketamine and Postoperative Outcomes After Total Knee Arthroplasty: Association with Revision Surgery and Analgesic Use. WebLog J Orthop. wjor.2025.l0303. https://doi.org/10.5281/zenodo.17865918
Read Full Article